1. Home
  2. INLX vs UNCY Comparison

INLX vs UNCY Comparison

Compare INLX & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INLX
  • UNCY
  • Stock Information
  • Founded
  • INLX 1996
  • UNCY 2016
  • Country
  • INLX United States
  • UNCY United States
  • Employees
  • INLX N/A
  • UNCY N/A
  • Industry
  • INLX EDP Services
  • UNCY Biotechnology: Pharmaceutical Preparations
  • Sector
  • INLX Technology
  • UNCY Health Care
  • Exchange
  • INLX Nasdaq
  • UNCY Nasdaq
  • Market Cap
  • INLX 49.1M
  • UNCY 58.7M
  • IPO Year
  • INLX N/A
  • UNCY 2021
  • Fundamental
  • Price
  • INLX $14.20
  • UNCY $0.55
  • Analyst Decision
  • INLX
  • UNCY Strong Buy
  • Analyst Count
  • INLX 0
  • UNCY 3
  • Target Price
  • INLX N/A
  • UNCY $5.33
  • AVG Volume (30 Days)
  • INLX 7.0K
  • UNCY 787.6K
  • Earning Date
  • INLX 03-24-2025
  • UNCY 05-12-2025
  • Dividend Yield
  • INLX N/A
  • UNCY N/A
  • EPS Growth
  • INLX N/A
  • UNCY N/A
  • EPS
  • INLX N/A
  • UNCY N/A
  • Revenue
  • INLX $18,018,373.00
  • UNCY N/A
  • Revenue This Year
  • INLX $8.12
  • UNCY N/A
  • Revenue Next Year
  • INLX N/A
  • UNCY N/A
  • P/E Ratio
  • INLX N/A
  • UNCY N/A
  • Revenue Growth
  • INLX 6.70
  • UNCY N/A
  • 52 Week Low
  • INLX $5.85
  • UNCY $0.20
  • 52 Week High
  • INLX $16.50
  • UNCY $1.60
  • Technical
  • Relative Strength Index (RSI)
  • INLX 57.62
  • UNCY 49.02
  • Support Level
  • INLX $11.70
  • UNCY $0.57
  • Resistance Level
  • INLX $11.54
  • UNCY $0.65
  • Average True Range (ATR)
  • INLX 0.44
  • UNCY 0.05
  • MACD
  • INLX 0.18
  • UNCY -0.00
  • Stochastic Oscillator
  • INLX 96.35
  • UNCY 28.20

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document strategy to convert documents from one medium to another.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

Share on Social Networks: